| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Cingulate Inc. (NASDAQ:CING) shares are soaring Friday.
Last week, the company announced a Precision Timed Release (PTR) technology, designed to enhance ADHD drug delivery. The company’s technology aims to improve the onset and efficacy of existing ADHD treatments. Zacks Small-Cap Research also issued a note with a $70 valuation on the stock earlier this week.
Trading Volume: The stock opened at $6.63 and has traded within a day range of $6.01 to $9.69. The 50-day moving average stands at $5.81. Cingulate’s short interest has decreased by 75.73% since its last report, now at 51,000 shares, which is 3.18% of its float.
Key Metrics Recap:
Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. For example, some stock, like Berkshire Hathaway, or Amazon.com, can cost thousands of dollars to own just one share. However, if you only want to invest a fraction of that, brokerages will allow you to do so.
In the the case of Cingulate (NASDAQ:CING), which is trading at $8.2 as of publishing time, $100 would buy you 12.2 shares of stock.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.
CING Price Action: Cingulate shares were up by 15% at $7.42 according to Benzinga pro.
See Also:
Image via Shutterstock.
Posted In: CING
